Developed by the biotech company ICOS, the drug tadalafil was approved by the FDA in late 2003 for the treatment of erectile dysfunction (ED, or male impotence). Marketed by the pharmaceutical firm Ely...
Q: I have seen a variety of online pharmacies advertising Cialis. How can I make sure I'm getting the real thing when I order Cialis? A: It always pays to be careful when you order Cialis, especially when...
The drug Cialis was approved by the FDA in 2003 for the treatment of erectile dysfunction (ED). Since then, millions of men have turned to Cialis for the safe and effective treatment of their ED. With...
Where to Find Information About Cialis and Erectile Dysfunction If you’re looking for information about Cialis and other erectile dysfunction treatments, the Internet is an excellent resource offering...
Viagra, Cialis and Levitra have taken over the erectile dysfunction (ED) market. In fact, Viagra alone is breaking all sales records for prescription drugs of any sort. Not surprisingly, the triad - Viagra...
Can The Weekend Pill Take On The Little Blue Pill And Win? Dr Ruut N. Tuten, our straight-shooting sex doctor, is back to answer a few emails from readers. In the mailbag this week: questions about the...
The marketing gurus at Ely Lilly probably don't need our help to come up with a sales pitch for Cialis , their blockbuster erectile dysfunction drug. Judging from the public's enthusiastic response to...
I'm the first to admit I got a cool job – actually two cool jobs. When the cameras are rolling, I get to be anybody as an actor. My name is Palms, Harry Palms, and when the camera turns off, that...
For years, researchers at the finest scientific institutes around the world have debated whether men really do think with their penises. In a poll, 85% admitted that studying that question was much more...
Yes, you've heard the story before, but I'm telling you there are all kinds of details they always leave out. I mean who do you want to believe? A shady nightclub owner or a police captain? The truth is...
Subscribe in a reader
